Product Use Limitations, Warranty, Disclaimer

IPSOGEN SA manufactures products for a number of intended uses. Please refer to the product label for the intended use statements for specific products.
Each IPSOGEN product is shipped with documentation stating specifications and other technical information. IPSOGEN products are warranted to meet the stated specifications. IPSOGEN's sole obligation and the customer's sole remedy are limited to replacement of products free of charge in the event products fail to perform as warranted.

IPSOGEN makes no other warranty of any kind whatsoever, and SPECIFICALLY DISCLAIMS AND EXCLUDES ALL OTHER WARRANTIES OF ANY KIND OR NATURE WHATSOEVER, DIRECTLY OR INDIRECTLY, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, AS TO THE SUITABILITY, PRODUCTIVITY, DURABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, MERCHANTABILITY, CONDITION, OR ANY OTHER MATTER WITH RESPECT TO IPSOGEN PRODUCTS.

In no event shall IPSOGEN be liable for claims for any other damages, whether direct, incidental, foreseeable, consequential, or special (including but not limited to loss of use, revenue or profit), whether based upon warranty, contract, tort (including negligence) or strict liability arising in connection with the sale or the failure of IPSOGEN products to perform in accordance with the stated specifications.

Please contact us for the most up-to-date information on IPSOGEN products.

For more information about security and chemical composition, Please refer to the Material Safety Data Sheet (MSDS) available upon request.

Trademarks

Ipsogen, FusionQuant®, ProfileQuant®, IpsoQuantTM, MutaQuantTM, MutaScreenTM and MapQuant DxTM are trademarks of IPSOGEN SA.

The names of actual companies and products mentioned herein and/or third party trademarks, trade names and logos contained herein may be the trademarks of their respective owners. Any rights not expressly granted herein are reserved.


Limited Use Label License: MapQuant DxTM Genomic Grade

The MapQuant DxTM Genomic Grade technology is protected by international patent application PCT/BE2006/00051 and foreign counterparts licensed exclusively worldwide to Ipsogen; US patent pending.